共 148 条
[1]
Charles C(2006)Systemic sclerosis: hypothesis-driven treatment strategies Lancet 367 1683-1691
[2]
Clements P(2010)Targeted therapy for systemic sclerosis: how close are we? Nat Rev Rheumatol 6 269-278
[3]
Furst DE(2011)Validation of new biomarkers in systemic autoimmune diseases Nat Rev Rheumatol 7 708-717
[4]
Ramos-Casals M(1991)The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis Arthritis Care Res 4 27-31
[5]
Fonollosa-Pla V(1980)Measurement of patient outcome in arthritis Arthritis Rheum 23 137-145
[6]
Brito-Zerón P(1982)The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales J Rheumatol 9 789-793
[7]
Sisó-Almirall A(1997)The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time Arthritis Rheum 40 1984-1991
[8]
Tektonidou MG(2001)The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial Arthritis Rheum 44 653-661
[9]
Ward MM(2005)Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms Clin Rheumatol 24 48-54
[10]
Poole JL(2005)Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ) Clin Rheumatol 24 3-10